Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy

Epilepsia

Volumn 51, Issue 9, 2010, Pages 1699-1706

  Landvogt, Christian ^a   Buchholz, Hans Georg ^a   Bernedo, Viviane ^a   Schreckenberger, Mathias ^a   Werhahn, Konrad J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Basal ganglia; Dopamine; Juvenile myoclonic epilepsy; Positron emission tomography

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FLUORINE 18; BENZAMIDE DERIVATIVE; DOPAMINE; FLUORINE; N-((1-ALLYL-2-PYRROLIDINYL)METHYL)-5-(3-FLUOROPROPYL)-2,3-DIMETHOXYBENZAMIDE; PYRROLIDINE DERIVATIVE;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORPUS STRIATUM; HUMAN; MALE; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; TEMPORAL LOBE; THALAMUS; TONIC CLONIC SEIZURE; VOXEL BASED MORPHOMETRY; ADOLESCENT; BASAL GANGLION; BRAIN; DIAGNOSTIC USE; HEMISPHERIC DOMINANCE; METABOLISM; MYOCLONIC EPILEPSY, JUVENILE; SCINTISCANNING; STATISTICS AND NUMERICAL DATA; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; BASAL GANGLIA; BENZAMIDES; BRAIN; CORPUS STRIATUM; DOPAMINE; FLUORINE RADIOISOTOPES; FUNCTIONAL LATERALITY; HUMANS; MALE; MYOCLONIC EPILEPSY, JUVENILE; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; PYRROLIDINES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TEMPORAL LOBE; TISSUE DISTRIBUTION;

EID: 77956330066     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02569.x     Document Type: Article

References (55)

1. Adamec RE 1990) Does kindling model anything clinically relevant? Biol Psychiatry 27 : 249 279.
2. Alexander GE, Crutcher MD 1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13 : 266 271.
3. al-Tajir G, Starr MS 1990) Anticonvulsant action of SCH 23390 in the striatum of the rat. Eur J Pharmacol 191 : 329 336.
4. Anlezark GM, Blackwood DH, Meldrum BS, Ram VJ, Neumeyer JL 1983) Comparative assessment of dopamine agonist aporphines as anticonvulsants in two models of reflex epilepsy. Psychopharmacology (Berl) 81 : 135 139.
5. Barone P, Parashos SA, Palma V, Marin C, Campanella G, Chase TN 1990) Dopamine D1 receptor modulation of pilocarpine-induced convulsions. Neuroscience 34 : 209 217.
6. Blumenfeld H 2005) Cellular and network mechanisms of spike-wave seizures. Epilepsia 46 (Suppl 9 21 33.
7. Bodenmann P, Ghika J, Van Melle G, Bogousslavsky J 2001) [Neurological comorbidity in parkinsonism]. Rev Neurol (Paris) 157 : 45 54.
8. Bozzi Y, Vallone D, Borrelli E 2000) Neuroprotective role of dopamine against hippocampal cell death. J Neurosci 20 : 8643 8649.
9. Brett M, Anton J-L, Valabregue R, Poline J-B 2002) Region of interest analysis using an SPM toolbox [Abstract]. Neuroimage 16 : 497.
10. Burke K, Chandler CJ, Starr BS, Starr MS 1990) Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse. Pharmacol Biochem Behav 36 : 729 733.
11. Chen SC 2006) Epilepsy and migraine: the dopamine hypotheses. Med Hypotheses 66 : 466 472.
12. Ciumas C, Wahlin TB, Jucaite A, Lindstrom P, Halldin C, Savic I 2008) Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy. Neurology 71 : 788 794.
13. Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y 2004) Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors. J Neurochem 89 : 834 843.
14. Cropley VL, Innis RB, Nathan PJ, Brown AK, Sangare JL, Lerner A, Ryu YH, Sprague KE, Pike VW, Fujita M 2008) Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. Synapse 62 : 399 408.
15. Depaulis A, Vergnes M, Marescaux C 1994) Endogenous control of epilepsy: the nigral inhibitory system. Prog Neurobiol 42 : 33 52.
16. Deransart C, Riban V, Le B, Marescaux C, Depaulis A 2000) Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat. Neuroscience 100 : 335 344.
17. Deransart C, Depaulis A 2002) The control of seizures by the basal ganglia? A review of experimental data Epileptic Disord 4 (Suppl 3 S61 S72.
18. Dichter MA, Heinemann U, Macdonald RL, Mody I, Moshe SL, Schwartzkroin A, Engel J Jr%. 2008) The neurobiology of epilepsy. in Engel J Jr%., Pedley TA Eds) Epilepsy - a comprehensive textbook. Lippincott Williams & Wilkins, Philadelphia, pp. 217 507.
19. Duncan JS 2005) Brain imaging in idiopathic generalized epilepsies. Epilepsia 46 (Suppl 9 108 111.
20. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr%., Sibley DR 1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 : 1429 1432.
21. Ginovart N, Wilson AA, Houle S, Kapur S 2004) Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats. Biol Psychiatry 55 : 1188 1194.
22. Gonzalez-Islas C, Hablitz JJ 2003) Dopamine enhances EPSCs in layer II-III pyramidal neurons in rat prefrontal cortex. J Neurosci 23 : 867 875.
23. Grace AA 1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41 : 1 24.
24. Hamacher K, Coenen HH, Stocklin G 1986) Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27 : 235 238.
25. ILAE-Classification 1989) Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30 : 389 399.
26. Jamora D, Lim SH, Pan A, Tan L, Tan EK 2007) Valproate-induced Parkinsonism in epilepsy patients. Mov Disord 22 : 130 133.
27. Janz D, Durner M 1998) Juvenile myoclonic epilepsy. In Engel J Jr%., Pedley TA Eds) Epilepsy: a comprehensive textbook. Lippincott-Raven Publishers, Philadelphia, pp. 2389 2400.
28. Joel D, Weiner I 2000) The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96 : 451 474.
29. Kaasinen V, Nagren K, Hietala J, Farde L, Rinne JO 2001) Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain. Am J Psychiatry 158 : 308 311.
30. Kim JH, Lee JK, Koh SB, Lee SA, Lee JM, Kim SI, Kang JK 2007) Regional grey matter abnormalities in juvenile myoclonic epilepsy: a voxel-based morphometry study. Neuroimage 37 : 1132 1137.
31. Lammertsma AA, Hume SP 1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4 : 153 158.
32. Li SC, Schoenberg BS, Wang CC, Cheng XM, Zhou SS, Bolis CL 1985) Epidemiology of epilepsy in urban areas of the People's Republic of China. Epilepsia 26 : 391 394.
33. Livingston S, Kadji L, Bridge EM 1948) The use of benzedrine and dexedrine sulphate in the treatment of epilepsy. J Pediartr 32 : 490 494.
34. Louw D, Sutherland GR, Glavin GB, Girvin J 1989) A study of monoamine metabolism in human epilepsy. Can J Neurol Sci 16 : 394 397.
35. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH 2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19 : 1233 1239.
36. Mervaala E, Andermann F, Quesney LF, Krelina M 1990) Common dopaminergic mechanism for epileptic photosensitivity in progressive myoclonus epilepsies. Neurology 40 : 53 56.
37. Mukherjee J, Yang ZY, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen CT, Mintzer R, Cooper M 1999) Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride. Nucl Med Biol 26 : 519 527.
38. Mukherjee J, Christian BT, Dunigan KA, Shi B, Narayanan TK, Satter M, Mantil J 2002) Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 46 : 170 188.
39. Penfield W, Jasper H 1954) Epilepsy and the functional anatomy of the human brain. Little Brown & Co, Boston.
40. Pintor M, Mefford IN, Hutter I, Pocotte SL, Wyler AR, Nadi NS 1990) Levels of biogenic amines, their metabolites, and tyrosine hydroxylase activity in the human epileptic temporal cortex. Synapse 5 : 152 156.
41. Ring HA, Trimble MR, Costa DC, Moriarty J, Verhoeff NP, Ell PJ 1994) Striatal dopamine receptor binding in epileptic psychoses. Biol Psychiatry 35 : 375 380.
42. Ristic AJ, Vojvodic N, Jankovic S, Sindelic A, Sokic D 2006) The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia 47 : 2183 2185.
43. Santens P, Claeys I, Vonck K, Boon P 2006) Parkinsonism due to lamotrigine. Mov Disord 21 : 2269 2270.
44. Seeck M, Dreifuss S, Lantz G, Jallon P, Foletti G, Despland PA, Delavelle J, Lazeyras F 2005) Subcortical nuclei volumetry in idiopathic generalized epilepsy. Epilepsia 46 : 1642 1645.
45. Siessmeier T, Zhou Y, Buchholz HG, Landvogt C, Vernaleken I, Piel M, Schirrmacher R, Rosch F, Schreckenberger M, Wong DF, Cumming P, Grunder G, Bartenstein P 2005) Parametric mapping of binding in human brain of d2 receptor ligands of different affinities. J Nucl Med 46 : 964 972.
46. Slaght SJ, Paz T, Mahon S, Maurice N, Charpier S, Deniau JM 2002) Functional organization of the circuits connecting the cerebral cortex and the basal ganglia: implications for the role of the basal ganglia in epilepsy. Epileptic Disord 4 (Suppl 3 S9 S22.
47. Starr MS 1996) The role of dopamine in epilepsy. Synapse 22 : 159 194.
48. Strauss H 1944) The effect of mental activity on the incidence of seizures and the electroencephalographic pattern in some epileptics. With remarks on the influence of amphetamine sulfate. Psychosom Med 6 : 141 145.
49. Theodore WH, Fisher RS 2004) Brain stimulation for epilepsy. Lancet Neurol 3 : 111 118.
50. Turski WA, Cavalheiro EA, Ikonomidou C, Bortolotto ZA, Klockgether T, Turski L 1990) Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures. Synapse 5 : 113 119.
51. Uhl GR 2003) Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism. Mov Disord 18 (Suppl 7 S71 S80.
52. Vercueil L, Benazzouz A, Deransart C, Bressand K, Marescaux C, Depaulis A, Benabid AL 1998) High-frequency stimulation of the subthalamic nucleus suppresses absence seizures in the rat: comparison with neurotoxic lesions. Epilepsy Res 31 : 39 46.
53. Vercueil L 2006) Epilepsy and neurodegenerative diseases in adults: a clinical review. Epileptic Disord 8 : S44 S54.
54. Werhahn KJ, Landvogt C, Klimpe S, Buchholz HG, Yakushev I, Siessmeier T, Muller-Forell W, Piel M, Rosch F, Glaser M, Schreckenberger M, Bartenstein P 2006) Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study. Epilepsia 47 : 1392 1396.
55. Yakushev IY, Dupont E, Buchholz HG, Tillmanns J, Debus F, Cumming P, Heimann A, Fellgiebel A, Luhmann HJ, Landvogt C, Werhahn KJ, Schreckenberger M, Potschka H, Bartenstein P 2010) In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy. Epilepsia 51 : 415 422.